KalVista Pharmaceuticals (KALV) Stock Price, Quote, News & History | Benzinga

KalVista Pharmaceuticals Inc (KALV) Stock Price, Quote, News & History

KALVNASDAQ

Trade with Public

Trade with Public

$26.94

N/A

At close: Jun 2, 5:00 PM EST

$26.94

N/A

After Hours: 5:29 PM EST

OverviewNews Earnings Events Options Analyst Ratings Insider Trades Short Interest Government Trades Stock Report

Key Statistics

Open

$26.95

Close

$26.94

Volume / Avg.

1.51M / 3.24M

Day Range

$26.94 - $26.95

52 Wk Range

9.83 - 26.98

Market Cap

$1.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

75

Short Interest

25.31%

Days to Cover

3.07

Recent Kalvista Pharmaceuticals Inc News

Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy

Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy.

Caroline Ryan

KalVista Details Early Sales, Prescriber Uptake For Newly Approved Rare Swelling Drug

KalVista reports early EKTERLY sales momentum, rising prescriber adoption and global regulatory approvals following the drug's 2025 launch.

Vandana Singh

Stock Market Today: Dow, Nasdaq 100 And S&P 500 Futures Gain After December Jobs Data— General Motors, Tilray In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs, the lede, and headline were updated in the story.) U.S. stock futures advanced on Friday after a mixed Thursday. Futures of major benchmark indices were trading higher.

Rishabh Mishra

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

-

Free Cash Flow (TTM)

-

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-

Analyst Trends and Forecast

1

Dec 25

3

Jan

2

Mar

0

0

0

0

Apr

1

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.30B

PE Ratio (TTM)

-

PE Ratio (FWD)

25.45

PEG Ratio (TTM)

-

PS Ratio (TTM)

972.53

PB Ratio (TTM)

-

Earnings Yield % (TTM)

-14.62%

Earnings Yield % (FWD)

3.93%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

-$0.37

Company Debt

Total Debt

$139.40M

LT Debt

$139.40M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$213.77M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$26.95

Close

$26.94

Volume / Avg.

1.51M / 3.24M

Day Range

$26.94 - $26.95

52 Wk Range

9.83 - 26.98

Market Cap

$1.43B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

75

Short Interest

25.31%

Days to Cover

3.07

About

Sector

Health Care

Industry

Biotechnology

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discove...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy KalVista Pharmaceuticals (KALV) stock?

A

You can purchase shares of KalVista Pharmaceuticals (NASDAQ:KALV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are KalVista Pharmaceuticals (KALV) competitors?

A

There are no as such competitors for KalVista Pharmaceuticals.

Q

What is the forecast, or price target, for KalVista Pharmaceuticals (KALV) stock?

A

KalVista Pharmaceuticals has a consensus price target of $28.30.

Q

What is the current price for KalVista Pharmaceuticals (KALV)?

A

The stock price for KalVista Pharmaceuticals (NASDAQ: KALV) is $26.94 last updated June 2, 2026 at 5:29 PM EDT.

Q

Does KalVista Pharmaceuticals (KALV) pay a dividend?

A

There are no upcoming dividends for KalVista Pharmaceuticals.

Q

When is KalVista Pharmaceuticals (NASDAQ:KALV) reporting earnings?

A

KalVista Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is KalVista Pharmaceuticals (KALV) going to split?

A

There is no upcoming split for KalVista Pharmaceuticals.

Q

What sector and industry does KalVista Pharmaceuticals (KALV) operate in?

A

KalVista Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.